Date:
07-May-26
Broker:
Stifel
Recommendation:
Hold
Old Target:
10.00
New Target:
10.00
Rating Type:
Reiteration
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Sharecast News) - hVIVO announced on Thursday that it has signed a £6m clinical trial agreement with a clinical-stage biopharmaceutical company to conduct an influenza human challenge trial.
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
Date:
24-Apr-26
Action:
Sell
Notifier:
Brendan Buckley
(Non-Executive Director)
Price:
8.65
Amount:
2,017,000
Holding:
6,017,539
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Sharecast News) - hVIVO said on Wednesday that it has secured a contract to conduct what it described as the world's first pivotal phase three human challenge trial for a whooping cough vaccine, mark...
Date:
22-Apr-26
Broker:
Shore Capital
Recommendation:
Buy
Old Target:
-
New Target:
-
Rating Type:
Reiteration